Vicarious Surgical Inc. has presented details about its advanced surgical robot, which is specifically designed for general surgery. The robot leverages proprietary decoupled actuators aimed at enhancing ease of use, clinical outcomes, and economic efficiency across high-volume surgical procedures. The company has established fortified manufacturing capabilities and an integrated supply chain, ready for scaling operations. Vicarious Surgical is supported by leading partners, including HCA and major investors such as Khosla Ventures and Bill Gates. The presentation highlights a significant market opportunity, with a potential value of $150 billion and 45 million addressable abdominal robotic procedures worldwide per year. Currently, 96% of these procedures are conducted manually, with robotic adoption hindered by factors such as high costs, limited access, and difficulties in use and training. You can access the full presentation through the link below.